[1] |
GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics[J]. World J Gastroenterol, 2015, 21(1): 60-83. DOI: 10.3748/wjg.v21.i1.60.
|
[2] |
BÖTTCHER K, ROMBOUTS K, SAFFIOTI F, et al. MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation[J]. Hepatology, 2018, 68(1): 172-186. DOI: 10.1002/hep.29782.
|
[3] |
FLOREANI A, RESTREPO-JIMÉNEZ P, SECCHI MF, et al. Etiopathogenesis of autoimmune hepatitis[J]. J Autoimmun, 2018, 95: 133-143. DOI: 10.1016/j.jaut.2018.10.020.
|
[4] |
SHARIFF MI, MAGGS J, HENEGHAN MA. Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand[J]. Hepatology, 2013, 57(4): 1677. DOI: 10.1002/hep.25963.
|
[5] |
GUHE V, SONI B, INGALE P, et al. Autophagy proteins and its homeostasis in cellular environment[J]. Adv Protein Chem Struct Biol, 2021, 123: 73-93. DOI: 10.1016/bs.apcsb.2019.12.002.
|
[6] |
LEE KW, THIYAGARAJAN V, SIE HW, et al. Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells[J]. J Nutr Biochem, 2014, 25(9): 903-913. DOI: 10.1016/j.jnutbio.2014.04.001.
|
[7] |
CHUNG Y, RAHIM MN, GRAHAM JJ, et al. An update on the pharmacological management of autoimmune hepatitis[J]. Expert Opin Pharmacother, 2021, 22(11): 1475-1488. DOI: 10.1080/14656566.2021.1895747.
|
[8] |
AN HAACK I, DERKOW K, RIEHN M, et al. The role of regulatory CD4 T cells in maintaining tolerance in a mouse model of autoimmune hepatitis[J]. PLoS One, 2015, 10(11): e0143715. DOI: 10.1371/journal.pone.0143715.
|
[9] |
SZEKERCZÉS T, GÓGL A, ILLYÉS I, et al. Autophagy, mitophagy and microRNA expression in chronic hepatitis C and autoimmune hepatitis[J]. Pathol Oncol Res, 2020, 26(4): 2143-2151. DOI: 10.1007/s12253-020-00799-y.
|
[10] |
TINIAKOS DG, BRAIN JG, BURY YA. Role of histopathology in autoimmune hepatitis[J]. Dig Dis, 2015, 33(Suppl 2): 53-64. DOI: 10.1159/000440747.
|
[11] |
ZHUANG Y, LI Y, LI X, et al. Atg7 knockdown augments concanavalin a-induced acute hepatitis through an ROS-mediated p38/MAPK pathway[J]. PLoS One, 2016, 11(3): e0149754. DOI: 10.1371/journal.pone.0149754.
|
[12] |
PUA HH, DZHAGALOV I, CHUCK M, et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation[J]. J Exp Med, 2007, 204(1): 25-31. DOI: 10.1084/jem.20061303.
|
[13] |
PERL A, FERNANDEZ D, TELARICO T, et al. Endogenous retroviral pathogenesis in lupus[J]. Curr Opin Rheumatol, 2010, 22(5): 483-492. DOI: 10.1097/BOR.0b013e32833c6297.
|
[14] |
WEINDEL CG, RICHEY LJ, BOLLAND S, et al. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation[J]. Autophagy, 2015, 11(7): 1010-1024. DOI: 10.1080/15548627.2015.1052206.
|
[15] |
FAN X, MEN R, HUANG C, et al. Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation[J]. Cell Death Dis, 2020, 11(1): 23. DOI: 10.1038/s41419-019-2217-6.
|
[16] |
LI Y, TANG Y, WANG S, et al. Endogenous n-3 polyunsaturated fatty acids attenuate T cell-mediated hepatitis via autophagy activation[J]. Front Immunol, 2016, 7: 350. DOI: 10.3389/fimmu.2016.00350.
|
[17] |
CUI B, LIN H, YU J, et al. Autophagy and the immune response[J]. Adv Exp Med Biol, 2019, 1206: 595-634. DOI: 10.1007/978-981-15-0602-4_27.
|
[18] |
GOLBABAPOUR S, BAGHERI-LANKARANI K, GHAVAMI S, et al. Autoimmune hepatitis and stellate cells: An insight into the role of autophagy[J]. Curr Med Chem, 2020, 27(35): 6073-6095. DOI: 10.2174/0929867326666190402120231.
|
[19] |
YANG Z, KLIONSKY DJ. Mammalian autophagy: Core molecular machinery and signaling regulation[J]. Curr Opin Cell Biol, 2010, 22(2): 124-131. DOI: 10.1016/j.ceb.2009.11.014.
|
[20] |
JUNG CH, RO SH, CAO J, et al. mTOR regulation of autophagy[J]. FEBS Lett, 2010, 584(7): 1287-1295. DOI: 10.1016/j.febslet.2010.01.017.
|
[21] |
CAI SL, TEE AR, SHORT JD, et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning[J]. J Cell Biol, 2006, 173(2): 279-289. DOI: 10.1083/jcb.200507119.
|
[22] |
KERKAR N, DUGAN C, RUMBO C, et al. Rapamycin successfully treats post-transplant autoimmune hepatitis[J]. Am J Transplant, 2005, 5(5): 1085-1089. DOI: 10.1111/j.1600-6143.2005.00801.x.
|
[23] |
AGARWAL S, TIWARI SK, SETH B, et al. Activation of autophagic flux against xenoestrogen bisphenol-a-induced hippocampal neurodegeneration via AMP kinase (AMPK)/mammalian target of rapamycin (mTOR) pathways[J]. J Biol Chem, 2015, 290(34): 21163-21184. DOI: 10.1074/jbc.M115.648998.
|
[24] |
HAN JH, PARK HS, LEE DH, et al. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift[J]. Life Sci, 2021, 267: 118978. DOI: 10.1016/j.lfs.2020.118978.
|
[25] |
FAN X, MEN R, WANG H, et al. Methylprednisolone decreases mitochondria-mediated apoptosis and autophagy dysfunction in hepatocytes of experimental autoimmune hepatitis model via the Akt/mTOR signaling[J]. Front Pharmacol, 2019, 10: 1189. DOI: 10.3389/fphar.2019.01189.
|
[26] |
LI S, XIA Y, CHEN K, et al. Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3[J]. Drug Des Devel Ther, 2016, 10: 631-647. DOI: 10.2147/DDDT.S99420.
|
[27] |
WU L, WANG C, LI J, et al. Hepatoprotective effect of quercetin via TRAF6/JNK pathway in acute hepatitis[J]. Biomed Pharmacother, 2017, 96: 1137-1146. DOI: 10.1016/j.biopha.2017.11.109.
|
[28] |
YU Q, LIU T, LI S, et al. The protective effects of levo-tetrahydropalmatine on ConA-induced liver injury are via TRAF6/JNK signaling[J]. Mediators Inflamm, 2018, 2018: 4032484. DOI: 10.1155/2018/4032484.
|
[29] |
XU S, WU L, ZHANG Q, et al. Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice[J]. Life Sci, 2017, 185: 103-113. DOI: 10.1016/j.lfs.2017.07.033.
|
[30] |
LI J, XIA Y, LIU T, et al. Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis[J]. PLoS One, 2015, 10(3): e0120440. DOI: 10.1371/journal.pone.0120440.
|
[31] |
NAKAHIRA K, HASPEL JA, RATHINAM VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome[J]. Nat Immunol, 2011, 12(3): 222-230. DOI: 10.1038/ni.1980.
|
[32] |
ZHONG Z, UMEMURA A, SANCHEZ-LOPEZ E, et al. NF-κB restricts inflammasome activation via elimination of damaged mitochondria[J]. Cell, 2016, 164(5): 896-910. DOI: 10.1016/j.cell.2015.12.057.
|
[33] |
TRAVASSOS LH, CARNEIRO LA, RAMJEET M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry[J]. Nat Immunol, 2010, 11(1): 55-62. DOI: 10.1038/ni.1823.
|
[34] |
CORREA RG, MILUTINOVIC S, REED JC. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases[J]. Biosci Rep, 2012, 32(6): 597-608. DOI: 10.1042/BSR20120055.
|
[35] |
FENG Q, YAO J, ZHOU G, et al. Quantitative proteomic analysis reveals that arctigenin alleviates concanavalin A-induced hepatitis through suppressing immune system and regulating autophagy[J]. Front Immunol, 2018, 9: 1881. DOI: 10.3389/fimmu.2018.01881.
|
[36] |
WANG YQ, LI XY, YANG L, et al. Expression of autophagy gene in PBMCs and correlation between Th17/CD4+CD25+CD127lowTreg cells and liver function in autoimmune hepatitis[J]. Chin J Lab Diagn, 2020, 24(6): 934-940. DOI: 10.3969/j.issn.1007-4287.2020.06.013.
汪永强, 李显勇, 杨琳, 等. 自身免疫肝炎患者外周血PBMCs自噬基因表达及Th17/CD4+CD25+CD127lowTreg细胞与肝脏功能相关性研究[J]. 中国实验诊断学, 2020, 24(6): 934-940. DOI: 10.3969/j.issn.1007-4287.2020.06.013.
|